TABLE 1.
Demographic characteristics of GC patients (n = 49)
Variablea | Value |
---|---|
Median age (yrs) (range) | 62 (52–67) |
No. (%) of patients of gender | |
Male | 31 (63.27) |
Female | 18 (36.73) |
Median BMI (kg/cm2) (range) (n = 47) | 20.96 (19.31–22.50) |
No. (%) of patients with tumor site | |
Antrum | 10 (20.41) |
Nonantrum | 39 (79.59) |
No. (%) of patients with histology | |
Low differentiation | 29 (64.44) |
Medium differentiation | 3 (6.12) |
High differentiation | 2 (4.08) |
Unknown | 15 (30.61) |
No. (%) of patients with metastasis | |
Yes | 26 (53.06) |
No | 23 (46.94) |
No. (%) of patients with liver metastasis (n = 26) | |
Yes | 13 (50.00) |
No | 13 (50.00) |
No. (%) of patients with surgery | |
Yes | 30 (61.22) |
No | 19 (38.78) |
No. (%) of patients with no. of lines of treatment of: | |
<3 | 26 (53.06) |
≥3 | 7 (14.29) |
None | 16 (32.53) |
No. (%) of patients with ECOG score of: | |
0 | 29 (59.18) |
1 | 15 (30.61) |
2 | 5 (10.20) |
No. (%) of patients with clinical response | |
PD | 17 (34.69) |
Non-PD | 20 (40.82) |
Unknown | 12 (24.49) |
Median NLR (range) | 1.91 (1.29–2.63) |
Median PLR (range) | 147.50 (103.94–210.09) |
Median MLR (range) | 0.22 (0.18–0.32) |
Median CA125 (U/ml) (range) (n = 39) | 23.30 (11.90–62.10) |
Median CA199 (U/ml) (range) (n = 48) | 7.10 (3.15–19.30) |
Median CEA (μg/liter) (range) (n = 48) | 1.97 (1.26–5.12) |
Median CA153 (U/ml) (range) (n = 26) | 7.45 (5.30–9.90) |
Median ALB (g/liter) (range) | 38.70 (36.10–41.75) |
Median GLB (g/liter) (range) | 26.20 (22.55–28.90) |
Median LDH (U/liter) (range) | 165.00 (146.00–183.00) |
Median ALP (U/liter) (range) | 85.00 (73.00–118.50) |
Median progress-free survival (mos) (range) (n = 33) | 6.07 (3.32–8.75) |
Abbreviations: NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; MLR, monocyte-to-lymphocyte ratio; CA125, carbohydrate antigen 125; CEA, carcinoembryonic antigen; ALB, albumin; GLB, globulin; LDH, lactate dehydrogenase; ALP, alkaline phosphatase. Range, quartiles (P25, P75).